Business
Precipio Announces Q4 and year-end 2024 Shareholder Update Call
Conference Call to be held on March 31st, 2025 at 5:00 PM ESTNEW HAVEN, Conn., March 17, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q4 and year end 2024 corporate update call on March 31st, 2025 at 5:00 PM ET. The call will include updates on all of the company’s current core businesses. The conference call may be accessed by calling 844-695-5519 (international callers dial 1-412-902-6760). All callers should ask for the Preci
About this update from Precipio, Inc.
[{"type":"image","alt":"Precipio, Inc.","displaySize":"","headline":null,"caption":"Precipio, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":59,"url":"https://media.zenfs.com/en/globenewswire.com/ab6e80c50d815f9c4c3c5c7425f16fed"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/zOITnXM5v3wqbUHIrLobqQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTgzO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/ab6e80c50d815f9c4c3c5c7425f16fed","width":300,"height":59}},"lazy":false},{"type":"text","content":"Conference Call to be held on March 31st, 2025 at 5:00 PM EST","length":61,"tagName":"p"},{"type":"text","content":"NEW HAVEN, Conn., March 17, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q4 and year end 2024 corporate update call on March 31st, 2025 at 5:00 PM ET. The call will include updates on all of the company’s current core businesses.","length":307,"tagName":"p"},{"type":"text","content":"The conference call may be accessed by calling 844-695-5519 (international callers dial 1-412-902-6760). All callers should ask for the Precipio Inc. conference call. Participants may also pre-register for the conference call to https://dpregister.com/sreg/10197585/fea81a2627 and will receive a calendar invite and a direct dial-in number, bypassing the operator.","length":369,"tagName":"p"},{"type":"text","content":"Listeners interested in submitting questions in advance should email their questions to [email protected] and management will do its best to address those questions during the call.","length":193,"tagName":"p"},{"type":"text","content":"A replay of the call will be available approximately 24 hours after the call and may be accessed via the Investors page on Precipio's website, https://www.precipiodx.com/investors/.","length":190,"tagName":"p"},{"type":"text","content":"About Precipio","length":14,"tagName":"p","attribs":{}},{"type":"text","content":"Precipio is a healthcare biotechnology company focused on cancer diagnostics. Our mission is to address the pervasive problem of cancer misdiagnoses by developing solutions in the form of diagnostic products and services. Our products and services deliver higher accuracy, improved laboratory workflow, and ultimately better patient outcomes, which reduce healthcare expe...